Clinical Trials Browser

Phase 3 × Recruiting × Lymphoma × Clear all

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

NCT06191744 2026-04-13

EPCORE™FL-2

Phase 3 Recruiting

1,095 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT06522737 2026-04-06

TERZO

Phase 3 Recruiting

124 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral

NCT06084936 2026-04-02

GLOBRYTE

Phase 3 Recruiting

182 enrolled

Lymphoid

Lymphoma

NCT07188558 2026-03-04

PiNACLE-H2H

Phase 3 Recruiting

400 enrolled

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05006482 2026-01-13

GEM-S

Phase 3 Recruiting

668 enrolled

Lymphoid

Lymphoma

NCT05929222 2025-12-24

FIL_GAZEBO

Phase 3 Recruiting

190 enrolled

Lymphoid

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT05328258 2023-10-27

ProFertil

Phase 3 Recruiting

500 enrolled

LymphoidSarcoma

Lymphoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT03647072 2018-08-27

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Phase 3 Recruiting

60 enrolled

Lymphoid

Lymphoma

Clinical Trials

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

EPCORE™FL-2

TERZO

GLOBRYTE

PiNACLE-H2H

GEM-S

FIL_GAZEBO

ProFertil

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy